PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-09-08
- Last Posted Date
- 2020-12-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 408
- Registration Number
- NCT01430559
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
🇨🇳Anhui Province Hospital, Hefei, Anhui, China
🇨🇳The First Affiliated Hospital of Shantou Medical Collage, Shantou City, Guangdong, China
A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults
- First Posted Date
- 2011-09-07
- Last Posted Date
- 2012-04-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 29
- Registration Number
- NCT01429740
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
- Conditions
- Chronic Noncancer Pain
- Interventions
- First Posted Date
- 2011-09-05
- Last Posted Date
- 2016-11-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 395
- Registration Number
- NCT01428583
- Locations
- 🇺🇸
Crossroads Research, Owings Mills, Maryland, United States
🇺🇸Drug Study Institute, Jupiter, Florida, United States
🇺🇸Sarasota Pain Medicine Research, Sarasota, Florida, United States
Systematic Review And Meta-Analysis Of Psoriasis Treatments.
- Conditions
- Psoriasis
- First Posted Date
- 2011-08-29
- Last Posted Date
- 2018-12-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT01425138
A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease
- First Posted Date
- 2011-08-23
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 19
- Registration Number
- NCT01422187
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2014-12-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 80
- Registration Number
- NCT01421303
- Locations
- 🇧🇪
Universitair Ziekenhuis Gent, Gent, Belgium
A Study to Determine Whether an Oral Drops Formulation of Triazolam is Bioequivalent to a Tablet Formulation in Healthy Subjects
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2016-10-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 34
- Registration Number
- NCT01421043
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 109
- Registration Number
- NCT01421069
- Locations
- 🇳🇴
Depart. of Rheumatology, Oslo, Norway
🇸🇮University Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia
🇮🇹Centro di Ricerca Clinica - Fondazione dell'Universita' degli Studi "G. D'Annunzio", Chieti Scalo, Italy
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
- First Posted Date
- 2011-08-19
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 67
- Registration Number
- NCT01420081
- Locations
- 🇺🇸
University of Kansas Cancer Center and Medical Pavilion, Westwood, Kansas, United States
🇨🇦Princess Margaret Hospital, Toronto, Ontario, Canada
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
- First Posted Date
- 2011-08-17
- Last Posted Date
- 2012-10-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT01419041
- Locations
- 🇺🇸
Pfizer Investigational Site, Saint Paul, Minnesota, United States